Fascin immunoreactivity correlates with tumor grade in non-small cell lung cancer (NSCLC).

被引：0
|
作者：
del Rosario, A [1 ]
Goncharuk, VN [1 ]
Tran, TA [1 ]
Sheehan, CE [1 ]
Ross, JS [1 ]
机构：
[1] Albany Med Coll, Albany, NY 12208 USA
来源：
LABORATORY INVESTIGATION | 2001年 / 81卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1283
引用
收藏
页码：218A / 218A
页数：1
相关论文
共 50 条
  • [31] Induction therapy for non-small cell lung cancer (NSCLC)
    Nakamura, H
    Furukawa, K
    Ikeda, N
    Shibuya, H
    Tanaka, K
    Okunaka, T
    Hirano, T
    Sakai, M
    Saito, M
    Konaka, C
    Kato, H
    XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 1029 - 1033
  • [32] EZH2 expression is an early event in the pathogenesis of non-small cell lung cancer (NSCLC) and correlates with tumor progression
    Behrens, Carmen
    Yuan, Ping
    Solis, Luisa
    Saintigny, Pierre
    Kadara, Humam
    Fujimoto, Junya
    Moran, Cesar
    Swisher, Stephen G.
    Heymach, John V.
    Wistuba, Ignacio I.
    CANCER RESEARCH, 2011, 71
  • [33] Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung Cancer
    Sharpnack, Michael F.
    Cho, Ju Hwan
    Johnson, Travis S.
    Otterson, Gregory A.
    Shields, Peter G.
    Huang, Kun
    Carbone, David P.
    He, Kai
    LUNG CANCER, 2020, 146 : 36 - 41
  • [34] Clinical and molecular correlates of tumor aneuploidy in metastatic non-small cell lung cancer
    Spurr, Liam F.
    Pitroda, Sean P.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [35] Overexpression of JAM-A in Non-Small Cell Lung Cancer Correlates with Tumor Progression
    Zhang, Min
    Luo, Wenting
    Huang, Bo
    Liu, Zihui
    Sun, Limei
    Zhang, Qingfu
    Qiu, Xueshan
    Xu, Ke
    Wang, Enhua
    PLOS ONE, 2013, 8 (11):
  • [36] Effect of primary tumor size in patients with metastatic non-small cell lung cancer (NSCLC).
    Xia, Bing
    Gao, Feng
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] Radiotherapy for oligometastatic tumor improved the prognosis of patients with non-small cell lung cancer (NSCLC)
    Gong, Hong-yun
    Wang, Yi
    Han, Guang
    Song, Qi-bin
    THORACIC CANCER, 2019, 10 (05) : 1136 - 1140
  • [38] Prognostic relevance of tumor ploidy assessed by karyotyping in non-small cell lung cancer (NSCLC)
    Wegrzynowicz, E
    Kardas, I
    Dziadziuszko, R
    Limon, J
    Kurowski, K
    Jassem, J
    LUNG CANCER, 2005, 49 : S150 - S150
  • [39] Tumor microcirculation based biomarker discovery strategy for non-small cell lung cancer (NSCLC)
    Breiva, D.
    Tracums, I.
    Jaunalksne, I.
    Krievins, D.
    Bistrova, A.
    Spaks, A.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S62 - S62
  • [40] Immunohistochemical study of tumor microinvasion in blood vessels at non-small cell lung cancer (NSCLC)
    Anistratov, Pavel A.
    Lazutin, Yury N.
    Sergostyants, Gennadiy Z.
    Vladimirova, Liubov Yu
    Pyltsin, Bergey P.
    Leyman, Igor A.
    Charitonova, Anna P.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345